Canadian Based Peptide Supplier|Ships from British Columbia, Canada|International Shipping Available|HPLC-Tested Batches|>99% Purity Specification|Same Day Shipping|Batch-Specific COAs|Canadian Based Peptide Supplier|Ships from British Columbia, Canada|International Shipping Available|HPLC-Tested Batches|>99% Purity Specification|Same Day Shipping|Batch-Specific COAs|Canadian Based Peptide Supplier|Ships from British Columbia, Canada|International Shipping Available|HPLC-Tested Batches|>99% Purity Specification|Same Day Shipping|Batch-Specific COAs|Canadian Based Peptide Supplier|Ships from British Columbia, Canada|International Shipping Available|HPLC-Tested Batches|>99% Purity Specification|Same Day Shipping|Batch-Specific COAs|
Volta Peptides Blog

Blog

In-depth articles on peptide science, research guides, and industry insights from the Volta Peptides team.

MOTS-c Guide: Mitochondrial Peptide for Canada Research
RegulatoryMay 12, 2026

MOTS-c Guide: Mitochondrial Peptide for Canada Research

MOTS-c stands out as a 16-amino-acid peptide encoded by mitochondrial DNA, distinct from nuclear-gene peptides. Discovered in 2015, it influences metabolic regulation, AMPK signaling, and aging mechanisms. This guide details its features, verification steps, and research applications for Canadian buyers.

3 min read
RegulatoryMay 12, 2026

Personal Information Protection Policy (Updated April 1, 2024)

This policy, last updated on April 1, 2024, outlines how personal information is collected, used, shared, and protected on websites offering peptide products and services. It covers consent exceptions, handling of sensitive data including medical health information, and rights for individuals, with special attention to minors under age 14. Users should review details on retention, security measures, and contact options before engaging with services.

4 min read
Top Research Peptides for Metabolic Fat Loss Studies in 2026
RegulatoryMay 12, 2026

Top Research Peptides for Metabolic Fat Loss Studies in 2026

Research into metabolic peptides has advanced with GLP-1, GIP, and glucagon receptor agonists leading fat loss studies. Retatrutide, the first triple agonist, shows greater weight reductions than predecessors in Phase 2 trials. This overview covers key compounds, mechanisms, and protocols for 2026 research.

4 min read
HPLC Testing for Peptides: Complete Guide to Purity Checks
RegulatoryMay 12, 2026

HPLC Testing for Peptides: Complete Guide to Purity Checks

HPLC testing serves as the main method for checking research peptide purity, with ≥99% purity as the standard for high-quality samples. This guide explains how HPLC works, what chromatograms reveal, and its role in verifying peptide quality. Researchers rely on it to ensure minimal impurities that could affect study results.

4 min read
Triptorelin: Synthetic GnRH Agonist for Hormone Research
RegulatoryMay 12, 2026

Triptorelin: Synthetic GnRH Agonist for Hormone Research

Triptorelin serves as a synthetic gonadotropin-releasing hormone agonist that regulates hormone levels for research into conditions like prostate cancer and endometriosis. It initially stimulates then desensitizes the pituitary gland, reducing LH, FSH, testosterone, and estrogen. Studies highlight its role in managing precocious puberty, breast cancer, and women's health issues, with a specific structure and proven efficacy in clinical trials.

4 min read
Key Blood Tests for Metabolic Health Monitoring
RegulatoryMay 12, 2026

Key Blood Tests for Metabolic Health Monitoring

Metabolic health testing provides insights into heart function and blood sugar control to promote longevity. It examines seven key biomarkers, including hemoglobin A1c, fasting blood sugar, and lipid panel, to detect issues like diabetes, thyroid disorders, kidney disease, and liver damage. Regular monitoring offers personalized plans and ongoing support for better health outcomes.

3 min read
Pharmaceutical Peptides: Growth, Challenges, and Key Methods
RegulatoryMay 12, 2026

Pharmaceutical Peptides: Growth, Challenges, and Key Methods

Over 80 pharmaceutical peptides have gained worldwide approval for treating endocrine, immune, and cardiovascular conditions. These short-chain amino acid polymers offer high selectivity, affinity, and low toxicity, fueling a market growing over 10% annually toward tens of billions by 2030. Despite benefits, challenges like synthesis complexity, stability issues, and high costs persist, addressed through advanced screening, purification, and modification techniques.

4 min read
PEGylation Extends Peptide Half-Life from Minutes to Days
RegulatoryMay 12, 2026

PEGylation Extends Peptide Half-Life from Minutes to Days

PEGylation surrounds peptides with a flexible polyethylene glycol layer to boost half-life from minutes to hours or days. This process increases hydrodynamic size, blocks proteases, and limits renal clearance while preserving receptor affinity. Such changes support less frequent dosing, improve patient adherence, cut costs, and enhance real-world efficacy.

4 min read
Peptide Pull-Down Assays for Antibody Target Validation
ScienceMay 12, 2026

Peptide Pull-Down Assays for Antibody Target Validation

Peptide pull-down assays confirm antibody specificity by immobilizing bait peptides to capture target proteins from crude extracts. These methods use biotinylated peptides bound to streptavidin-coupled magnetic beads, allowing rigorous washing to ensure specific binding. Early validation saves time and resources in drug discovery by eliminating nonspecific binders.

3 min read
ScienceMay 12, 2026

Peptides' Multifunctional Applications in Cancer Therapy

Peptides serve as versatile tools in cancer therapy due to their ability to target tumors precisely, deliver drugs, and disrupt key biological processes. They excel in tissue penetration and cellular uptake compared to antibodies, despite shorter half-lives. This article details their roles in delivering nanoparticles, extracellular vesicles, and interfering with receptors and protein interactions.

5 min read
RegulatoryMay 12, 2026

Research Use Only: What the Designation Actually Means

Research use only is the condition the material is sold under, not boilerplate attached afterwards. What it means, what follows from it on this site, what the buyer takes on, and what a Certificate of Analysis does and does not establish.

5 min read
RegulatoryMay 12, 2026

Purotoxin-1: Selective Blocker of P2X3 Receptors from Spider Venom

Purotoxin-1, derived from Geolycosa spider venom, acts as the first highly selective inhibitor of P2X3 receptors in the purinoreceptor family. This 35-amino-acid peptide with four disulfide bonds prolongs desensitization recovery in a concentration-dependent manner and shows promise in reducing inflammatory pain in rat models. Studies confirm its EK50 of 12 nM and full blockade at 100 nM, with no effects on other ion channels.

3 min read
RegulatoryMay 12, 2026

What Governs a Research Peptide Order at Volta

Ordering a research compound puts several separate documents into play. A plain-English map of which one decides what: research use, the contract, price and payment, shipping, returns and privacy, with the policy page that governs each.

4 min read
RegulatoryMay 12, 2026

Aclerastide: Effective Therapy for Diabetic Foot Ulcers

Aclerastide, an analog of angiotensin 1-7, shows strong potential in treating diabetic foot ulcers through progenitor proliferation, vascularization, collagen deposition, and re-epithelialization. Preclinical studies demonstrate its superiority over existing topical growth factors, with Phase II trials confirming faster wound closure lasting up to 20 weeks. Phase III trials are now recruiting patients.

3 min read
Aviptadil Acetate's Potential in Pulmonary Arterial Hypertension
RegulatoryMay 12, 2026

Aviptadil Acetate's Potential in Pulmonary Arterial Hypertension

Aviptadil acetate, a synthetic 28-amino-acid version of vasoactive intestinal peptide, shows promise for treating pulmonary arterial hypertension through inhalation. Studies report benefits like reduced pulmonary artery pressure, increased cardiac output, and improved walk tests in patients. Experimental work links VIP deficiency to PAH development in mice, supporting further evaluation of this compound.

3 min read
Atosiban Serves as Maintenance Therapy for Preterm Labor
RegulatoryMay 12, 2026

Atosiban Serves as Maintenance Therapy for Preterm Labor

Atosiban, an oxytocin-receptor antagonist marketed in China in 2006, offers maintenance treatment to manage preterm labor risks after initial tocolysis. Clinical trials show it delays delivery better than placebo in some cases and has fewer side effects than beta-2 agonists. Studies highlight its safety and role in reducing recurrent preterm labor episodes.

4 min read
High-Potency Multivitamin with Chelated Minerals for Better Absorption
ScienceMay 12, 2026

High-Potency Multivitamin with Chelated Minerals for Better Absorption

This multivitamin provides a comprehensive blend of vitamins and chelated minerals for energy, recovery, and wellness. It uses a patented chelated mineral system for high bioavailability and digestive ease. Key ingredients include high-dose B vitamins and supportive compounds like betaine HCl.

5 min read
TB4 Peptide: Key Functions and Research Insights
RegulatoryMay 12, 2026

TB4 Peptide: Key Functions and Research Insights

TB4 peptide, also known as thymosin beta 4, plays a central role in tissue repair, cell migration, and inflammation control in scientific studies. Researchers examine its ability to bind actin for better cell movement to damaged areas and promote new blood vessel growth. Ongoing lab work uses methods like HPLC purity analysis and cell-based assays to explore its potential in regeneration.

3 min read
How Volta Reviews What It Publishes
RegulatoryMay 12, 2026

How Volta Reviews What It Publishes

Volta sells the compounds it writes about, and no editorial process removes that conflict. What a process can do is make the content checkable by someone who does not trust us. The named reviewer, the source rules, and what the purity figures mean.

4 min read
Canada Approves First Generic Semaglutide: Prices and Timeline
RegulatoryMay 12, 2026

Canada Approves First Generic Semaglutide: Prices and Timeline

Health Canada authorized the first generic injectable semaglutide on April 28, 2026, making Canada the first G7 nation to approve it. This approval promises lower prices, with generics potentially dropping to $112 per pen as more enter the market, compared to the brand price of $320. A study shows that at $100 per month, nearly six times more Canadians would consider these treatments versus $400 per month.

3 min read
RegulatoryMay 12, 2026

Research Peptides Australia: 99%+ Purity, Testing, Fast Shipping

Research peptides like Retatrutide, Glutathione, and Melanotan I offer 99%+ HPLC purity with independent COA verification. Batches undergo testing for purity, identity, and sterility before sale. Australia-wide shipping via Australia Post includes tracking, with standard at $9.99 for 2-6 business days and free over $199.

3 min read
RegulatoryMay 12, 2026

Peptides Enabling Targeted and Efficient Drug Delivery

Peptides, made of amino acids linked by peptide bonds, offer high efficiency, low toxicity, and strong specificity for drug delivery. They address challenges like enzymatic breakdown, short half-lives, and poor cell penetration through targeted, cell-penetrating, responsive, and self-assembling designs. Combined with modifications and nanocarriers, peptides improve stability, bioavailability, and precise drug release in areas like cancer therapy and regenerative medicine.

4 min read
Retatrutide 30mg: Triple Agonist for Metabolic Research
RegulatoryMay 12, 2026

Retatrutide 30mg: Triple Agonist for Metabolic Research

Retatrutide 30mg, developed by Eli Lilly, acts as a triple agonist targeting GLP-1, GIP, and glucagon receptors to study weight regulation and energy balance. Research highlights its role in appetite control, glucose management, energy expenditure, and fat oxidation. Lab testing shows average purity of 99.93% and mass of 35.05 mg from Freedom Diagnostics on 2026-04-24, lot LY-3437943.

4 min read
Page 12 of 16

Showing 24 of 379 posts

Your Cart

Your cart is empty

Browse our catalog to add research compounds.